Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme 2 selected

Guidance programme

Showing 781 to 790 of 911

TitleReference numberPublishedLast updated
Sodium zirconium cyclosilicate for treating hyperkalaemiaTA599
Sofosbuvir for treating chronic hepatitis CTA330
Sofosbuvir–velpatasvir for treating chronic hepatitis CTA430
Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis CTA507
Solriamfetol for treating excessive daytime sleepiness caused by narcolepsyTA758
Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoeaTA777
Somapacitan for treating growth hormone deficiency in people 3 to 17 yearsTA1066
Somatrogon for treating growth disturbance in children and young people aged 3 years and overTA863
Sorafenib for treating advanced hepatocellular carcinomaTA474
Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancerTA781

Results per page

  1. 10
  2. 25
  3. 50
  4. All